logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Sgx Pharmaceuticals, Inc.


USPTO Granted Patents = 17


Forward Citations = 759

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Ruo W Steensma (14 out of 18 patents)

silverMedal Mark E Wilson (12 out of 26 patents)

bronzeMedal William D Arnold (12 out of 13 patents)

4.  Andreas Gosberg (12 out of 12 patents)

5.  Zhe Li (8 out of 54 patents)

6.  Ian A McDonald (8 out of 57 patents)

7.  Stephanie Hopkins (7 out of 9 patents)

8.  Stefan N Gradl (7 out of 7 patents)

9.  Chixu Chen (6 out of 14 patents)

10.  Pierre Bounaud (6 out of 6 patents)

11.  Pierre-Yves Bounaud (5 out of 6 patents)

12.  Brian Walter Eastman (4 out of 33 patents)

13.  Paul A Sprengeler (4 out of 4 patents)

14.  Christopher Ronald Smith (2 out of 27 patents)

15.  Elizabeth Anne Jefferson (2 out of 8 patents)


17 patents:

1. 8507489 - Bicyclic triazoles as protein kinase modulators (2013-08-13),
2. 8268994 - Fused ring heterocycle kinase modulators (2012-09-18),
3. 8242280 - Fused ring heterocycle kinase modulators (2012-08-14),
4. 8158647 - Substituted pyrrolopyridines and pyrazolopyridines as kinase modulators (2012-04-17),
5. 8071581 - Triazolopyridazine protein kinase modulators (2011-12-06),
6. 7977481 - Pyrimidinyl-thiophene kinase modulators (2011-07-12),
7. 7906648 - Pyrrolo-pyridine kinase modulators (2011-03-15),
8. 7829558 - Fused ring heterocycle kinase modulators (2010-11-09),
9. 7803806 - Pyrimidinyl-thiophene kinase modulators (2010-09-28),
10. 7709645 - Pyrrolo-pyridine kinase modulators (2010-05-04),
11. 7626021 - Fused ring heterocycle kinase modulators (2009-12-01),
12. 7601839 - Pyrrolo-pyridine kinase modulators (2009-10-13),
13. 7582637 - Pyrrolo-pyridine kinase modulators (2009-09-01),
14. 7473783 - Bicyclic pyrazolo protein kinase modulators (2009-01-06),
15. 7452993 - Fused ring heterocycle kinase modulators (2008-11-18),
SGX Pharmaceuticals, Inc. is a biotechnology company that specializes in the discovery and development of small molecule drugs to treat various types of cancer. With a focus on targeted therapies, SGX Pharmaceuticals aims to provide innovative treatment options for patients. The company's research and development efforts are centered around identifying promising drug candidates through its proprietary drug discovery platforms. Through strategic partnerships and collaborations, SGX Pharmaceuticals aims to accelerate the development and commercialization of its drug candidates for the benefit of cancer patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#326 in San Diego, CA

#4,375 in California

#18,330 in US

#34,858 in the World

...
San Diego, CA, United States of America

Sgx Pharmaceuticals, Inc.

Forward Citations = 759

26 inventors:

goldMedal Ruo W Steensma (14 out of 18 patents)

silverMedal Mark E Wilson (12 out of 26 patents)

bronzeMedal William D Arnold (12 out of 13 patents)

4.  Andreas Gosberg (12 out of 12 patents)

5.  Zhe Li (8 out of 54 patents)

Please report any incorrect information to support@idiyas.com
Loading…